10-Q Filing

BIOMERICA INC CIK: 73290 Q3 2014

Filing Information

Form Type	10-Q
Accession Number	`0001513162-14-000241`
Period End Date	20140228
Filing Date	20140414
Fiscal Year	2014
Fiscal Period	Q3
XBRL Instance	bmra-20140228.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 80 Cash Flow Statement 63

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$115.73K	USD	Point-in-time
Allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$120.41K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.47M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.32M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.67M	USD	Point-in-time
Accumulated depreciation and amortization (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$844.68K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.08M	USD	Point-in-time
Accumulated depreciation and amortization (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.16M	USD	Point-in-time
Preferred stock, Shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $120,405 and $115,730 as of February 28, 2014 and May 31, 2013, respectively	`AccountsReceivableNetCurrent`	$1.17M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $120,405 and $115,730 as of February 28, 2014 and May 31, 2013, respectively	`AccountsReceivableNetCurrent`	$871.66K	USD	Point-in-time
Preferred stock, Shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Inventories, net	`InventoryNet`	$1.57M	USD	Point-in-time
Preferred stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Inventories, net	`InventoryNet`	$1.94M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$196.68K	USD	Point-in-time
Preferred stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$141.01K	USD	Point-in-time
Preferred stock, No Par Value (in Dollars per share)	`PreferredStockNoParValue`	-	USD	Point-in-time
Deferred tax assets, current portion	`DeferredTaxAssetsNetCurrent`	$144.00K	USD	Point-in-time
Preferred stock, No Par Value (in Dollars per share)	`PreferredStockNoParValue`	-	USD	Point-in-time
Deferred tax assets, current portion	`DeferredTaxAssetsNetCurrent`	$144.00K	USD	Point-in-time
Common stock, Par Value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.08	USD	Point-in-time
Common stock, Par Value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.08	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.06M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.25M	USD	Point-in-time
Common stock, Shares Authorized	`CommonStockSharesAuthorized`	25.00M	shares	Point-in-time
Common stock, Shares Authorized	`CommonStockSharesAuthorized`	25.00M	shares	Point-in-time
Property and equipment, net of accumulated depreciation and amortization of $1,163,523 and $844,684 as of February 28, 2014 and May 31, 2013, respectively	`PropertyPlantAndEquipmentNet`	$640.47K	USD	Point-in-time
Property and equipment, net of accumulated depreciation and amortization of $1,163,523 and $844,684 as of February 28, 2014 and May 31, 2013, respectively	`PropertyPlantAndEquipmentNet`	$654.62K	USD	Point-in-time
Common stock, Shares Issued	`CommonStockSharesIssued`	7.51M	shares	Point-in-time
Common stock, Shares Issued	`CommonStockSharesIssued`	7.27M	shares	Point-in-time
Deferred tax assets, net of current portion	`DeferredTaxAssetsNetNoncurrent`	$85.00K	USD	Point-in-time
Deferred tax assets, net of current portion	`DeferredTaxAssetsNetNoncurrent`	$85.00K	USD	Point-in-time
Investments	`Investments`	$165.32K	USD	Point-in-time
Common stock, Shares Outstanding	`CommonStockSharesOutstanding`	7.27M	shares	Point-in-time
Common stock, Shares Outstanding	`CommonStockSharesOutstanding`	7.51M	shares	Point-in-time
Investments	`Investments`	$165.32K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$165.20K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$248.09K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$71.39K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$71.39K	USD	Point-in-time
Total assets	`Assets`	$6.27M	USD	Point-in-time
Total assets	`Assets`	$6.39M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$423.13K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$351.92K	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$120.32K	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$207.98K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$559.89K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$543.45K	USD	Point-in-time
Commitments and Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, no par value authorized 5,000,000 shares, none issued and none outstanding at February 28, 2014 and May 31, 2013	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value authorized 5,000,000 shares, none issued and none outstanding at February 28, 2014 and May 31, 2013	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.08 par value authorized 25,000,000 shares, issued and outstanding 7,513,714 and 7,274,714 at February 28, 2014 and May 31, 2013, respectively	`CommonStockValue`	$601.10K	USD	Point-in-time
Common stock, $0.08 par value authorized 25,000,000 shares, issued and outstanding 7,513,714 and 7,274,714 at February 28, 2014 and May 31, 2013, respectively	`CommonStockValue`	$581.98K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$18.29M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$18.03M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-9.01K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-10.12K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-12.77M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-13.16M	USD	Point-in-time
Total Shareholders' Equity	`StockholdersEquity`	$5.73M	USD	Point-in-time
Total Shareholders' Equity	`StockholdersEquity`	$5.83M	USD	Point-in-time
Total Liabilities and Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$6.27M	USD	Point-in-time
Total Liabilities and Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$6.39M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$1.49M	USD	1 Quarter
Net sales	`SalesRevenueNet`	$3.44M	USD	3 Qtrs
Net sales	`SalesRevenueNet`	$5.00M	USD	3 Qtrs
Net sales	`SalesRevenueNet`	$1.42M	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$3.06M	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$971.32K	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$914.16K	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$2.35M	USD	3 Qtrs
Gross profit	`GrossProfit`	$1.09M	USD	3 Qtrs
Gross profit	`GrossProfit`	$1.95M	USD	3 Qtrs
Gross profit	`GrossProfit`	$445.38K	USD	1 Quarter
Gross profit	`GrossProfit`	$578.56K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.10M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$358.53K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$405.77K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.11M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$150.18K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$353.90K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$140.18K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$368.22K	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$1.48M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$1.45M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$508.71K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$545.95K	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$-388.60K	USD	3 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$32.62K	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$-63.33K	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$496.31K	USD	3 Qtrs
Dividend and interest income	`InvestmentIncomeInterestAndDividend`	$9.32K	USD	3 Qtrs
Dividend and interest income	`InvestmentIncomeInterestAndDividend`	$13.68K	USD	3 Qtrs
Dividend and interest income	`InvestmentIncomeInterestAndDividend`	$3.48K	USD	1 Quarter
Dividend and interest income	`InvestmentIncomeInterestAndDividend`	$7.07K	USD	1 Quarter
Interest (expense) income	`InterestIncomeExpenseNet`	$-302.00	USD	3 Qtrs
Interest (expense) income	`InterestIncomeExpenseNet`	$-80.00	USD	3 Qtrs
Interest (expense) income	`InterestIncomeExpenseNet`	$6.00	USD	1 Quarter
Interest (expense) income	`InterestIncomeExpenseNet`	$-20.00	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$7.08K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$13.60K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$9.01K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$3.46K	USD	1 Quarter
(Loss) income before income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$36.08K	USD	1 Quarter
(Loss) income before income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-56.25K	USD	1 Quarter
(Loss) income before income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-375.00K	USD	3 Qtrs
(Loss) income before income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$505.33K	USD	3 Qtrs
(Provision) benefit for income taxes	`IncomeTaxExpenseBenefit`	$9.54K	USD	1 Quarter
(Provision) benefit for income taxes	`IncomeTaxExpenseBenefit`	$-20.64K	USD	1 Quarter
(Provision) benefit for income taxes	`IncomeTaxExpenseBenefit`	$9.54K	USD	3 Qtrs
(Provision) benefit for income taxes	`IncomeTaxExpenseBenefit`	$12.39K	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-35.61K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$26.54K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-384.53K	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$492.94K	USD	3 Qtrs
Basic net (loss) income per common share (in Dollars per share)	`EarningsPerShareBasic`	$-0.05	USD	3 Qtrs
Basic net (loss) income per common share (in Dollars per share)	`EarningsPerShareBasic`	$0.07	USD	3 Qtrs
Basic net (loss) income per common share (in Dollars per share)	`EarningsPerShareBasic`	-	USD	1 Quarter
Basic net (loss) income per common share (in Dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Diluted net (loss) income per common share (in Dollars per share)	`EarningsPerShareDiluted`	$0.07	USD	3 Qtrs
Diluted net (loss) income per common share (in Dollars per share)	`EarningsPerShareDiluted`	$-0.05	USD	3 Qtrs
Diluted net (loss) income per common share (in Dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Diluted net (loss) income per common share (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.31M	shares	3 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	6.97M	shares	3 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.38M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.00M	shares	1 Quarter
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.73M	shares	1 Quarter
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.41M	shares	3 Qtrs
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.31M	shares	3 Qtrs
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.00M	shares	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-35.61K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$26.54K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-384.53K	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$492.94K	USD	3 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-2.71K	USD	3 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.11K	USD	3 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-2.15K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.11K	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-37.77K	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$490.23K	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$25.43K	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-385.65K	USD	3 Qtrs

Cash Flow Statement 63 line items

Line Item	Tag	Value	Unit	Period
Amount due on agreement to purchase restricted stock	`AmountDueOnAgreementToPurchaseRestrictedStock`	$100.00K	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-35.61K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$26.54K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-384.53K	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$492.94K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$148.62K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$164.41K	USD	3 Qtrs
Stock option expense	`StockOptionPlanExpense`	$11.00K	USD	3 Qtrs
Stock option expense	`StockOptionPlanExpense`	$17.16K	USD	3 Qtrs
Change in provision for losses on accounts receivable	`ProvisionForDoubtfulAccounts`	$-4.13K	USD	3 Qtrs
Change in provision for losses on accounts receivable	`ProvisionForDoubtfulAccounts`	$4.67K	USD	3 Qtrs
Inventory reserve	`InventoryLIFOReservePeriodCharge`	$-6.71K	USD	3 Qtrs
Inventory reserve	`InventoryLIFOReservePeriodCharge`	$3.89K	USD	3 Qtrs
Decrease in deferred rent liability	`IncreaseDecreaseInDeferredRentLiability`	$-10.11K	USD	3 Qtrs
Decrease in deferred rent liability	`IncreaseDecreaseInDeferredRentLiability`	$-3.42K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$304.78K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-691.34K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-111.94K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$360.41K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$13.55K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-55.67K	USD	3 Qtrs
Accounts payable and other accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$7.36K	USD	3 Qtrs
Accounts payable and other accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$81.32K	USD	3 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$2.77K	USD	3 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-87.65K	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$30.87K	USD	3 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-852.90K	USD	3 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.50M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$117.36K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$249.41K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-117.36K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-249.41K	USD	3 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$150.00K	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$760.00	USD	Point-in-time
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$5.40K	USD	Point-in-time
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.02K	USD	Point-in-time
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$40.41K	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$17.27K	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$10.10K	USD	Point-in-time
Payments on line of credit or equipment loan	`RepaymentsOfBankDebt`	$43.00K	USD	3 Qtrs
Payments on line of credit or equipment loan	`RepaymentsOfBankDebt`	-	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.59K	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$167.28K	USD	3 Qtrs
Effect of exchange rate changes in cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-1.11K	USD	3 Qtrs
Effect of exchange rate changes in cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-2.71K	USD	3 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.24M	USD	3 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-804.11K	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.47M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.32M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.67M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.08M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.47M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.32M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.67M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.08M	USD	Point-in-time
Interest	`InterestPaid`	$302.00	USD	3 Qtrs
Interest	`InterestPaid`	$80.00	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	$108.16K	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	$9.54K	USD	3 Qtrs
Payment of international regulatory approval fees in exchange for $100,000 due on agreement to purchase Biomerica restricted stock	`StockIssuedDuringPeriodValueIssuedForPaymentOfInternationalApprovalFees`	-	USD	3 Qtrs
Payment of international regulatory approval fees in exchange for $100,000 due on agreement to purchase Biomerica restricted stock	`StockIssuedDuringPeriodValueIssuedForPaymentOfInternationalApprovalFees`	$100.00K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.